Parkside Financial Bank & Trust’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
Other funds holding VNDA
ACM
Parkside Financial Bank & Trust's VNDA Position: Q2 2026 in Review
Parkside Financial Bank & Trust opened a new position in Vanda Pharmaceuticals (VNDA) in Q2 2026: 1,000 shares worth $6.12K. The stake represents ﹤0.01% of the portfolio and ranks #1833 among its holdings. This is a return to the name: Parkside Financial Bank & Trust previously reported a position in VNDA as recently as Q2 2023.
Parkside Financial Bank & Trust first reported a position in VNDA in Q4 2018 and has held it in 18 quarters since. 172 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.
- Parkside Financial Bank & Trust held 1,000 shares of Vanda Pharmaceuticals worth $6.12K as of Q2 2026.
- Vanda Pharmaceuticals was a new Parkside Financial Bank & Trust position in Q2 2026.
- Vanda Pharmaceuticals made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #1833 holding.
- Parkside Financial Bank & Trust first reported a position in Vanda Pharmaceuticals in Q4 2018 and has held it in 18 quarters since.
- 172 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.
Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.